Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor
about
The dopamine metabolite 3-methoxytyramine is a neuromodulatorTrace amine-associated receptors as emerging therapeutic targetsThe emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activityTrace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine classInternational Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclatureTrace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical ImplicationsGenetically-encoded tools for cAMP probing and modulation in living systemsMethamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytesDeterminants involved in subtype-specific functions of rat trace amine-associated receptors 1 and 4Cyclic AMP control measured in two compartments in HEK293 cells: phosphodiesterase K(M) is more important than phosphodiesterase localizationThe role of GRK6 in animal models of Parkinson's disease and L-DOPA treatmentHuman and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.Bariatric endocrinology: principles of medical practice.Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development.Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptorBiased signaling at chemokine receptorsAvenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality.Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.Triphenylmethane dye activation of beta-arrestinBRET biosensors to study GPCR biology, pharmacology, and signal transduction.Biophysical techniques for detection of cAMP and cGMP in living cells.Integrated approaches to understanding antipsychotic drug action at GPCRs.Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling.Tyramine and β-phenylethylamine, from fermented food products, as agonists for the human trace amine-associated receptor 1 (hTAAR1) in the stomach.Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signalingTAAR1-dependent effects of apomorphine in mice.Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.MAGI Proteins Regulate the Trafficking and Signaling of Corticotropin-Releasing Factor Receptor 1 via a Compensatory Mechanism.The Case for TAAR1 as a Modulator of Central Nervous System Function.Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats.Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.Further insights into the pharmacology of the human trace amine-associated receptors: discovery of novel ligands for TAAR1 by a virtual screening approach.Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies.The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.A cAMP Biosensor-Based High-Throughput Screening Assay for Identification of Gs-Coupled GPCR Ligands and Phosphodiesterase Inhibitors.TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC.Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397.
P2860
Q21091097-CE146E46-4D8D-47C0-8FD3-6D871CE09244Q22242286-35A52604-277C-4DDA-A85E-013A9A7A2B5BQ22242368-6168D004-A848-406A-A4BA-1107589D8349Q22252340-E9983104-0480-411D-A7A8-28893A67F8A2Q24634650-B948997C-F9F0-4099-BDBB-EB3C907A12ABQ26752602-1F52F6BD-920C-491D-AA4C-35EE6EE6017BQ26781567-B3EE2BAB-BB6C-4B86-9F12-FB4E1DE0AFF0Q28242470-4DC3F062-AE7D-4716-8083-736B3803E351Q28704020-83FA2486-EAC0-498B-A1BF-9F9A91978EDCQ28740548-017A4304-ECFE-4E62-9CB2-5A3D79F137C0Q30506209-7E73703F-1EC7-4451-8054-976C0456C06CQ33499502-8903C176-2AEE-412A-9C79-070B32AB2882Q33677790-EE04BE33-F4A1-4CAF-A604-5F111EFF7C85Q34007358-DF9FDADD-591F-41F1-B183-217AB181F866Q34199625-E8071DE1-C5C7-418D-B0A8-EA60CEF0F112Q35188101-FA653E65-D3EC-4EF6-B2F4-66C6E4510E9AQ35351711-BD3C764C-D485-405C-98E2-59B15C1BA4ECQ36746446-EAF1216F-5A01-4080-B7E8-2524A7C093C4Q36750306-729CFB99-F4DA-4B1D-98F3-FEFEC25B1EB7Q36870038-51AC82C6-D078-4422-8F54-9C475395A3EBQ37096786-0B40171A-FB73-4DCA-A1BF-FA540FA26A34Q38041105-7B51A70F-7AF9-407A-9E1E-53F46AD87797Q38098831-10D32752-6364-4838-8702-1044FBFACA8FQ38200335-7A125C9E-35D2-45BA-9749-036EB5A42B5DQ38883453-225DB451-F222-4F1D-9BC5-A26840EB77A6Q39022680-BB4937E7-6A23-488E-8719-36FEBF1974FEQ41018207-5217B9EE-4637-433E-93B1-489B13AAF0BEQ45743520-34B4BA6B-0031-4A03-811C-35D049D91843Q46025171-F97EA801-013F-4D8A-99E7-19357247F4F5Q46335711-7DF2817A-AD6C-4FBB-AF2E-B0874A57DDCCQ47640093-2AABB74D-9372-4C8E-94ED-17221FDA2C9BQ48171776-3E5AFEEF-1CE0-492A-BCC7-0D2F753B954BQ48275344-AAF6B92B-D573-4B2A-8A0F-78FE009A3108Q48281018-9301D868-B111-4DDD-A8A2-967E3C914FA8Q48413428-234596E2-6350-4513-BF18-F3DF6B7BE868Q51733160-ED64F31E-7A13-4D97-ADC1-C599FE23046BQ52656382-D26F65C9-E04A-4E75-84EA-9D1E0AA71043Q53551796-92A0AF9F-3B17-4BCE-AD2D-EAF7A18ACCABQ54124939-2303D06C-94BF-42E1-9453-5720D76790ACQ55446730-40D779F5-E65A-4CEE-A7A7-10D7D28789C0
P2860
Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pharmacological characterizati ...... energy transfer cAMP biosensor
@ast
Pharmacological characterizati ...... energy transfer cAMP biosensor
@en
Pharmacological characterizati ...... energy transfer cAMP biosensor
@nl
type
label
Pharmacological characterizati ...... energy transfer cAMP biosensor
@ast
Pharmacological characterizati ...... energy transfer cAMP biosensor
@en
Pharmacological characterizati ...... energy transfer cAMP biosensor
@nl
prefLabel
Pharmacological characterizati ...... energy transfer cAMP biosensor
@ast
Pharmacological characterizati ...... energy transfer cAMP biosensor
@en
Pharmacological characterizati ...... energy transfer cAMP biosensor
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Pharmacological characterizati ...... energy transfer cAMP biosensor
@en
P2093
Ali Salahpour
Jonathan D Violin
Larry S Barak
Marc G Caron
Robert J Lefkowitz
Tatyana D Sotnikova
Xiaodong Zhang
P2860
P304
P3181
P356
10.1124/MOL.108.048884
P407
P577
2008-06-04T00:00:00Z